Skip to main content
Top
Literature
1.
go back to reference Pachner M, Vokurka S, Koza V, Svoboda T, Hrabetova M, Jindra P et al (2013) Spontaneous remission of acute myeloid leukemia—a single center case reports. Klin Onkol 26(2):140–142CrossRef Pachner M, Vokurka S, Koza V, Svoboda T, Hrabetova M, Jindra P et al (2013) Spontaneous remission of acute myeloid leukemia—a single center case reports. Klin Onkol 26(2):140–142CrossRef
2.
go back to reference Musto P, D'Arena G, Melillo L, Cascavilla N, La Sala A, Ladogana S et al (1994) Spontaneous remission in acute myeloid leukaemia: a role for endogenous production of tumour necrosis factor and interleukin-2? Br J Haematol 87(4):879–880CrossRef Musto P, D'Arena G, Melillo L, Cascavilla N, La Sala A, Ladogana S et al (1994) Spontaneous remission in acute myeloid leukaemia: a role for endogenous production of tumour necrosis factor and interleukin-2? Br J Haematol 87(4):879–880CrossRef
4.
go back to reference Wulf GG, Jahns-Streubel G, Hemmerlein B, Bonnekessen K, Wormann B, Hiddemann W (1998) Plasmacytosis in acute myeloid leukemia: two cases of plasmacytosis and increased IL-6 production in the AML blast cells. Ann Hematol 76(6):273–277CrossRef Wulf GG, Jahns-Streubel G, Hemmerlein B, Bonnekessen K, Wormann B, Hiddemann W (1998) Plasmacytosis in acute myeloid leukemia: two cases of plasmacytosis and increased IL-6 production in the AML blast cells. Ann Hematol 76(6):273–277CrossRef
Metadata
Title
Does Development of Plasmacytosis have a Role in Spontaneous Remission of Acute Myeloid Leukemia?
Authors
Nishant Jindal
Ram Nampoothiri
Sweta Rajpal
Sreejesh Sreedharanunni
Neelam Varma
Pankaj Malhotra
Publication date
01-01-2021
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 1/2021
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-020-01293-w

Other articles of this Issue 1/2021

Indian Journal of Hematology and Blood Transfusion 1/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine